GLP1R and diabetes mellitus: These agents mimic GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying to improve glycemic control, as indicated by reduced HbA1c level, a crucial measure in diabetes care [2, 3].